Tallac Therapeutics

Provider of immune-therapy based treatment for oncology

placeBurlingame, California, United States calendar_todayFounded 2020 groups24 employees language tallactherapeutics.com

Registered entities

Innovation

12 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 959 times.

YearFilings
20191
20201
20212
20225
20237
20245
20254

Social engagement

Social engagement: 2.2K social following, 2 posts in the last 12 months — top quartile of its industry.

Investor mix

5 investors on record; lead investors include VenBio, Morningside, Lightstone Ventures, Matrix Partners China.

Investor typeCountShare
Venture capital5100%
Coming soon